The Northwell Health Cancer Institute announced today it has recruited Jeff Boyd, PhD, a renowned expert in cancer genetics research and clinical molecular diagnostics, as vice president and chief scientific officer and director of the Cancer Institute’s Center for Genomic Medicine. He will also hold an appointment as professor and member of the Cold Spring Harbor Laboratory Cancer Center.
“Genomics has become an important piece to helping us understand the genetic roots of the various forms of cancer, which is why it has become an important area of investment for Northwell Health,” said Richard Barakat, MD, physician-in-chief and director of the Northwell Health Cancer Institute, and senior vice president of cancer services at Northwell Health. “We are extremely fortunate to have such an esteemed cancer researcher and internationally-known genomics expert such as Dr. Boyd to join the Cancer Institute’s leadership team.”
In his new role, Dr. Boyd will develop a state-of-the-art Molecular Diagnostics Laboratory for Northwell’s Cancer Institute designed to deliver point-of-care genomic testing designed to provide the best possible treatment options to cancer patients. He will also foster academic relationships with Northwell’s scientific collaborators, including the basic cancer researchers at the Cold Spring Harbor Laboratory Cancer Center, the oncology researchers at the health system and at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
